A neurostimulation device has been cleared for post-C-section pain; a new plaque psoriasis treatment; the FDA addresses the contrast agent shortage; Lucentis biosimilar treatment is approved; and the recall is expanded for an over-the-counter laxative.
Stay up-to-date on the latest drugs in development.
Approval was based on a prospective study that included 44 participants who underwent C-section delivery.
Default number of doses in opioid prescriptions lowered for teens and young adults undergoing tonsillectomy
On average, products contained 10 to 20 percent more cannabidiol than advertised overall
The Simplist ready-to-administer prefilled syringes minimize preparation steps for clinicians.
The designation was based on data from two phase 2 proof-of-concept studies that evaluated VX-548 for acute pain following abdominoplasty or bunionectomy surgery.
Higher prescription of oral morphine equivalents seen for adults with cerebral palsy, spina bifida across pain categories
Propofol is an IV general anesthetic and sedative drug used in the induction and maintenance of anesthesia or sedation.
First Relief is a wearable PENS device that is placed behind the ear.
